- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from plants
Patent holdings for IPC class C07K 16/16
Total number of patents in this class: 269
10-year publication summary
22
|
23
|
27
|
21
|
8
|
19
|
14
|
19
|
17
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mabylon AG | 18 |
11 |
Regeneron Pharmaceuticals, Inc. | 4233 |
10 |
Vanderbilt University | 1890 |
8 |
Hoffmann-La Roche Inc. | 3387 |
7 |
Northern Bank Limited | 68 |
6 |
IgGenix, Inc. | 17 |
6 |
Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 202 |
5 |
Taisho Pharmaceutical Co., Ltd. | 868 |
5 |
The Board of Regents of the University of Texas System | 2202 |
5 |
CZ Biohub Sf, LLC | 126 |
5 |
Institute for Research in Biomedicine | 98 |
4 |
Seoul National University R&db Foundation | 3522 |
4 |
F. Hoffmann-La Roche AG | 7923 |
3 |
The General Hospital Corporation | 4710 |
3 |
Japan Science and Technology Agency | 1339 |
3 |
Agrosavfe N.V. | 9 |
3 |
Biostrategies LC | 11 |
3 |
Etat Francais Represente Par le Delegue General pour L'armement | 55 |
3 |
Teknologian Tutkimuskeskus VTT | 248 |
3 |
Corteva Agriscience LLC | 2660 |
3 |
Other owners | 169 |